Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study.

Giulia CassoneAndreina ManfrediFabiola AtzeniVincenzo VeneritoCaterina VacchiValentina PicernoFederica FuriniGian Luca ErrePaola TomiettoAnna Laura FedeleGiovanni Della CasaValeria NuceraChiara GiannittiCarlo SalvaraniMarco Sebastiani

Published in: Journal of clinical medicine (2020)

The management of RA-ILD patients remains a critical unmet medical need. Waiting for prospective controlled studies, ABA has shown a good safety profile in our cohort of Italian RA-ILD patients.

Keyphrases

interstitial lung disease
end stage renal disease
rheumatoid arthritis
systemic sclerosis
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
prognostic factors
peritoneal dialysis
idiopathic pulmonary fibrosis
clinical trial
disease activity
ankylosing spondylitis